Pearl Pathways, part of Versiti Clinical Trials

Pearl Pathways provides clinical, regulatory, quality and research-ethics support for biopharmaceutical, medical-device and diagnostic developers. Its services include development strategy, global filings, quality systems, GxP auditing, study support and medical writing. Versiti acquired Pearl Pathways in November 2023, and the Pearl team now operates within the consolidated Versiti Clinical Trials platform. The former Pearl Pathways website and domain-bound general contact channel have been retired.